Rani Therapeutics Holdings, Inc. Shares of Class A Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 25th, 2022 • Rani Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Rani Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (each an “Agent” and together, the “Agents”), as follows:
